Marker Therapeutics – Next-Generation T-Cell-Based Immunotherapies
Juan Vera, CEO of Marker Therapeutics, a clinical-stage immuno-oncology company focused on developing next-generation T cell-based immunotherapies for t...
3315 articles
Juan Vera, CEO of Marker Therapeutics, a clinical-stage immuno-oncology company focused on developing next-generation T cell-based immunotherapies for t...
Andrew Cutler, Clinical Associate Professor of Psychiatry at SUNY Upstate Medical University and CEO of Florida Clinical Research Center, LLC discusses ...
Aetion Chief Science Officer, Nicolle Gatto, Ph.D., M.P.H., shares how the organization leverages real-world evidence (RWE) to support research and deve...
Lora Sparkman, RN, BSN, MHA, VP, Partner, Clinical Solutions, Patient Safety and Quality at Relias and Nurse.com ambassador, discusses the current mater...
David Stein, PhD, CEO of Babson Diagnostics discusses how Babson is reimagining the blood testing process by only using only a pea-sized amount of blood...
Sujal Shah, President and CEO of CymaBay Therapeutics, a clinical-stage biopharmaceutical company, discusses the positive topline results from its Phase...
Michelle Wulfestieg, Executive Director at Southern California Hospice Foundation and CEO of Heavenly Home discusses how she is fighting the battle of h...
Tracy Curley, the CEO of iSpecimen, an online global marketplace that connects scientists requiring biospecimens for medical research with a network of ...
Comilla Sasson, MD, PhD, Vice President for Healthcare Business Solutions at the American Heart Association and a practicing Emergency Medicine physicia...
Vin Singh, Founder and CEO of BullFrog AI, a precision medicine company, discusses their bfLEAP Platform and how leveraging the power of AI and machine ...